An interaction study of Ocimum sanctum L. and levetiracetam in pentylenetetrazole kindling model of epilepsy.
Animals
Anticonvulsants
/ administration & dosage
Avoidance Learning
/ drug effects
Disease Models, Animal
Drug Therapy, Combination
Epilepsy
/ drug therapy
Herb-Drug Interactions
Kindling, Neurologic
/ drug effects
Levetiracetam
/ administration & dosage
Male
Maze Learning
/ drug effects
Ocimum sanctum
/ chemistry
Oxidative Stress
/ drug effects
Pentylenetetrazole
/ pharmacology
Plant Extracts
/ administration & dosage
Rats
Rats, Wistar
Seizures
/ drug therapy
Kindling
Levetiracetam
Levetiracetam (PubChem CID: 5284583)
Neurobehavioral
Ocimum sanctum
Oleanolic acid (PubChem CID: 10494)
Oxidative stress
Ursolic acid (PubChem CID: 64945)
Journal
Journal of ethnopharmacology
ISSN: 1872-7573
Titre abrégé: J Ethnopharmacol
Pays: Ireland
ID NLM: 7903310
Informations de publication
Date de publication:
01 Mar 2020
01 Mar 2020
Historique:
received:
17
01
2019
revised:
24
07
2019
accepted:
11
11
2019
pubmed:
19
11
2019
medline:
4
6
2020
entrez:
19
11
2019
Statut:
ppublish
Résumé
Ocimum sanctum L. commonly known as tulsi (synonym of Ocimum tenuiflorum L.) is widely used in Ayurveda medicine and is having multitude neuromodulatory effect including the anticonvulsant effect in acute seizure models as per previous studies. In India, it is used for the treatment of epilepsy as traditional medicine. However, its role in chronic seizure model and interaction with newer antiepileptic drugs has not been investigated, which will enhance its translational value. Current study investigated the effect of Ocimum on chronic seizure model and its interaction with levetiracetam (LEV), a newer antiepileptic drug. The adjuvant role of Ocimum sanctum hydroalcoholic extracts (OSHE) 1000 mg/kg along with LEV 300 mg/kg was studied in adult male Wistar rats with mean weight of 227.84 ± 21.68 g using pentylenetetrazole (30 mg/kg, i.p.) kindling (K) (with maximum 24 injections on alternate days and challenge on 7th-day). Along with seizure score, neurobehavioral, brain tissue oxidative stress and histopathology status were assessed. Pharmacokinetic interaction was assessed between LEV and OSHE after 14 days of drug treatment. K-LEV + OSHE had least seizure score during kindling and on the pentylenetetrazole-challenge test (p=0.031) than other kindling groups. Seizure protection was more in K-LEV + OSHE (85.72%) than others (K-LEV-42.86%, K-OSHE-42.86%, and K-Control-28.58%). Ocimum treated groups had better memory retention potential as evident from Morris water maze (MWM), passive avoidance test but not in an elevated plus maze test. Oxidative-stress was lower in Ocimum treated groups than K-Control group. As per histopathology, K-LEV + OSHE group had the least neuronal degeneration among kindling groups. There was no significant pharmacokinetic interaction between LEV and OSHE, except increased T Ocimum per se and combination with levetiracetam treatment exerted better seizure control, memory retention, oxidative stress reduction, and neuronal structure preservation than kindling control group. There was a very minimal drug interaction between Ocimum and LEV. So, Ocimum as an adjuvant to LEV may be shelpful in enhancing the antiepileptic effect and also in minimizing the adverse effects.
Identifiants
pubmed: 31739106
pii: S0378-8741(19)30221-1
doi: 10.1016/j.jep.2019.112389
pii:
doi:
Substances chimiques
Anticonvulsants
0
Plant Extracts
0
Levetiracetam
44YRR34555
Pentylenetetrazole
WM5Z385K7T
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112389Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.